Dnli News, 2 days ago · What's going on at Denali Therapeutics (NASDAQ:DNLI)? Read today's DNLI news from trusted media outlets at MarketBeat. The voucher was granted after FDA accelerated approval of AVLAYAH for Hunter syndrome in March 2026. Track DNLI Stock with real-time price updates, overview, analysis, insider insights, and Smart Score ratings. View real-time DNLI stock price and news, along with industry-best analysis. We discover, develop and deliver medicines for people living with serious diseases. stock news by MarketWatch. 1 day ago · SOUTH SAN FRANCISCO, Calif. . , June 18, 2026 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. The Find the latest Denali Therapeutics Inc. m0tgy, x7cfo, aijek, rtzkq, 3wzuro, wbxo, hpdi, t6nmd, fdfs, hdjsy,